Good morning :)
Place Order
Add to Watchlist

IND Swift Laboratories Ltd

INDSWFTLAB Share Price

94.216.83% (+6.02)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹534 cr, stock is ranked 1,784

Stock is 4.01x as volatile as Nifty

INDSWFTLAB Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

Low

Undervalued compared to the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹534 cr, stock is ranked 1,784

Stock is 4.01x as volatile as Nifty

INDSWFTLAB Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
1.510.57
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
35.346.490.86%

INDSWFTLAB Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

INDSWFTLAB Company Profile

Ind-Swift Laboratories Limited is a company focused on the development of active pharmaceutical ingredients (APIs).

INDSWFTLAB Similar Stocks (Peers)

Compare with peers 
PE Ratio
36.61
1Y Return
16.44%
Buy Reco %
87.88
PE Ratio
22.57
1Y Return
0.64%
Buy Reco %
74.19
PE Ratio
55.52
1Y Return
16.45%
Buy Reco %
72.00
PE Ratio
18.37
1Y Return
9.23%
Buy Reco %
53.33
PE Ratio
48.76
1Y Return
11.91%
Buy Reco %
81.25
Compare with Peers

INDSWFTLAB Forecasts

INDSWFTLAB Forecast

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

INDSWFTLAB

Income

Balance Sheet

Cash Flow

INDSWFTLAB Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 14.34%, vs industry avg of 9.02%

Increasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.4% to 0.45%

Higher than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 70.82%, vs industry avg of 15.28%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue667.85737.46784.01876.44813.04914.041,082.231,240.811,712.86896.93
Raw Materialssubtract352.08377.52374.40421.46409.10457.35581.87673.70628.51406.67
Power & Fuel Costsubtract22.6526.7530.7039.1536.4038.8460.2777.8463.51
Employee Costsubtract66.8569.6588.1297.63102.72106.55127.09135.84152.81
Selling & Administrative Expensessubtract55.3663.1981.2162.1074.8979.1662.8063.6580.66
Operating & Other expensessubtract62.5279.0258.7810.1812.1526.6211.0853.73101.20
Depreciation/Amortizationsubtract84.7588.2686.62104.0590.0687.29131.0457.3653.3013.39
Interest & Other Itemssubtract106.4288.3728.2192.20107.49100.2295.5592.1751.10-10.78
Taxes & Other Itemssubtract-24.10-16.1614.0120.731.4221.1614.6838.92160.80133.64
EPS-14.33-9.124.866.21-3.96-0.53-0.368.0371.1459.91
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00

INDSWFTLAB Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2021

Annual report

PDF

Investor Presentation

Nov 18PDF
Jul 31PDF
 

INDSWFTLAB Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
IND Swift Laboratories Ltd1.270.57
Sun Pharmaceutical Industries Ltd36.615.960.96%
Cipla Ltd22.574.441.09%
Torrent Pharmaceuticals Ltd55.5215.481.02%

INDSWFTLAB Stock Price Comparison

Compare INDSWFTLAB with any stock or ETF
Compare INDSWFTLAB with any stock or ETF
INDSWFTLAB
Loading...

INDSWFTLAB Shareholdings

INDSWFTLAB Promoter Holdings Trend

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 1.06%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

INDSWFTLAB Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Increased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has increased by 2.61%

Tickertape Separator

INDSWFTLAB Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding40.94%0.00%0.91%3.07%55.07%

Aug 2024

Sep 2024

Dec 2024

Mar 2025

INDSWFTLAB Shareholding History

MarJunAugSepDec '24Mar0.25%1.26%0.85%0.65%0.46%3.07%

INDSWFTLAB Insider Trades & Bulk Stock Deals

Loading...

smallcases containing INDSWFTLAB stock

Looks like this stock is not in any smallcase yet.

INDSWFTLAB Events

INDSWFTLAB Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

INDSWFTLAB has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

INDSWFTLAB Upcoming Dividends

No upcoming dividends are available

INDSWFTLAB Past Dividends

Cash Dividend

Ex DateEx DateSep 20, 2011

Final
Final | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Sep 20, 2011

Cash Dividend

Ex DateEx DateSep 16, 2010

Final
Final | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Sep 16, 2010

INDSWFTLAB Stock News & Opinions

Corporate
Ind-Swift Laboratories schedules board meeting

Ind-Swift Laboratories will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Ind-Swift Laboratories adjourns board meeting

Ind-Swift Laboratories has adjourned the meeting of the Board of Directors which was scheduled to be held on 12 February 2025. The meeting will now be held on 13 February 2025.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Ind-Swift Laboratories announces cessation of director

Ind-Swift Laboratories announced the cessation of Dr. Ashwani Kumar Vig as Independent Director of the Company on completion of his tenure with effect from 13 February 2025. Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Ind-Swift Laboratories adjourns board meeting

Ind-Swift Laboratories has adjourned the meeting of the Board of Directors which was scheduled to be held on 12 February 2025. The meeting will now be held on 13 February 2025.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Ind-Swift Laboratories to announce Quarterly Result

Ind-Swift Laboratories will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Ind-Swift Laboratories to hold EGM

Ind-Swift Laboratories announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 22 February 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Ind-Swift Laboratories consolidated net profit declines 98.70% in the September 2024 quarter

Net profit of Ind-Swift Laboratories declined 98.70% to Rs 0.41 crore in the quarter ended September 2024 as against Rs 31.66 crore during the previous quarter ended September 2023. Sales declined 95.87% to Rs 11.96 crore in the quarter ended September 2024 as against Rs 289.71 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales11.96289.71 -96 OPM %-98.6622.67 - PBDT0.8051.95 -98 PBT0.5838.77 -99 NP0.4131.66 -99 Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Ind-Swift Laboratories to declare Quarterly Result

Ind-Swift Laboratories will hold a meeting of the Board of Directors of the Company on 11 November 2024.Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Ind-Swift Laboratories to hold AGM

Ind-Swift Laboratories announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

9 months agoCapital Market - Live
Earnings
Ind-Swift Laboratories consolidated net profit declines 94.55% in the June 2024 quarter

Net profit of Ind-Swift Laboratories declined 94.55% to Rs 0.94 crore in the quarter ended June 2024 as against Rs 17.24 crore during the previous quarter ended June 2023. Sales declined 89.31% to Rs 33.17 crore in the quarter ended June 2024 as against Rs 310.34 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales33.17310.34 -89 OPM %-29.3619.43 - PBDT1.2345.52 -97 PBT0.9831.64 -97 NP0.9417.24 -95 Powered by Capital Market - Live

9 months agoCapital Market - Live

Frequently asked questions

  1. What is the share price of IND Swift Laboratories Ltd (INDSWFTLAB) today?

    The share price of INDSWFTLAB as on 4th June 2025 is ₹94.21. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on IND Swift Laboratories Ltd (INDSWFTLAB) share?

    The past returns of IND Swift Laboratories Ltd (INDSWFTLAB) share are
    • Past 1 week: 14.53%
    • Past 1 month: 21.01%
    • Past 3 months: 9.15%
    • Past 6 months: -4.97%
    • Past 1 year: -6.07%
    • Past 3 years: 53.44%
    • Past 5 years: 260.27%

  3. What are the peers or stocks similar to IND Swift Laboratories Ltd (INDSWFTLAB)?
  4. What is the market cap of IND Swift Laboratories Ltd (INDSWFTLAB) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of IND Swift Laboratories Ltd (INDSWFTLAB) is ₹534.60 Cr as of 4th June 2025.

  5. What is the 52 week high and low of IND Swift Laboratories Ltd (INDSWFTLAB) share?

    The 52-week high of IND Swift Laboratories Ltd (INDSWFTLAB) is ₹186 and the 52-week low is ₹68.72.

  6. What is the PE and PB ratio of IND Swift Laboratories Ltd (INDSWFTLAB) stock?

    The P/E (price-to-earnings) ratio of IND Swift Laboratories Ltd (INDSWFTLAB) is 1.27. The P/B (price-to-book) ratio is 0.57.

  7. Which sector does IND Swift Laboratories Ltd (INDSWFTLAB) belong to?

    IND Swift Laboratories Ltd (INDSWFTLAB) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy IND Swift Laboratories Ltd (INDSWFTLAB) shares?

    You can directly buy IND Swift Laboratories Ltd (INDSWFTLAB) shares on Tickertape. Simply sign up, connect your demat account and place your order.